| Bradley Don Britton, MD | |
|
14701 N Santa Fe Ave, Edmond, OK 73013-3411 | |
| (405) 752-2733 | |
| (405) 752-2172 |
| Full Name | Bradley Don Britton |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 14701 N Santa Fe Ave, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033112016 | NPI | - | NPPES |
| 5845266 | Other | OK | AETNA |
| 1462581 | Other | OK | UNITED HEALTHCARE |
| 100107780A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 17588 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newman Memorial Hospital | Shattuck, OK | Hospital |
| Summit Medical Center | Edmond, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Britton Vision Associates Inc | 4688659519 | 8 |
News Archive
Kaiser Health News: "Consumers and employers who provide health insurance are scrambling to understand what will change in their premiums and benefits once provisions of the recently passed law go into effect." Some of the answers they seek are unclear because the legislation leaves out details the health department must fill in during the regulatory process.
Research from Sweden shows that while people with asthma are as likely to be mildly active or inactive as people without, there is a strong relationship between vigorous physical activity and the respiratory condition.
Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.
Region Skåne, has selected LABVANTAGE to deliver a $4 million turn-key solution for digitizing the histopathological workflows of the whole region. The system will possibly be the largest such installation in the world and among the first in northern Europe.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 3 days ago
| Entity Name | Britton Vision Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427051408 PECOS PAC ID: 4688659519 Enrollment ID: O20040623000902 |
News Archive
Kaiser Health News: "Consumers and employers who provide health insurance are scrambling to understand what will change in their premiums and benefits once provisions of the recently passed law go into effect." Some of the answers they seek are unclear because the legislation leaves out details the health department must fill in during the regulatory process.
Research from Sweden shows that while people with asthma are as likely to be mildly active or inactive as people without, there is a strong relationship between vigorous physical activity and the respiratory condition.
Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.
Region Skåne, has selected LABVANTAGE to deliver a $4 million turn-key solution for digitizing the histopathological workflows of the whole region. The system will possibly be the largest such installation in the world and among the first in northern Europe.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 3 days ago
| Entity Name | Creek Nation Hospital & Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366593923 PECOS PAC ID: 5698786226 Enrollment ID: O20070821000130 |
News Archive
Kaiser Health News: "Consumers and employers who provide health insurance are scrambling to understand what will change in their premiums and benefits once provisions of the recently passed law go into effect." Some of the answers they seek are unclear because the legislation leaves out details the health department must fill in during the regulatory process.
Research from Sweden shows that while people with asthma are as likely to be mildly active or inactive as people without, there is a strong relationship between vigorous physical activity and the respiratory condition.
Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.
Region Skåne, has selected LABVANTAGE to deliver a $4 million turn-key solution for digitizing the histopathological workflows of the whole region. The system will possibly be the largest such installation in the world and among the first in northern Europe.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley Don Britton, MD 14701 N Santa Fe Ave, Edmond, OK 73013-3411 Ph: (405) 752-2733 | Bradley Don Britton, MD 14701 N Santa Fe Ave, Edmond, OK 73013-3411 Ph: (405) 752-2733 |
News Archive
Kaiser Health News: "Consumers and employers who provide health insurance are scrambling to understand what will change in their premiums and benefits once provisions of the recently passed law go into effect." Some of the answers they seek are unclear because the legislation leaves out details the health department must fill in during the regulatory process.
Research from Sweden shows that while people with asthma are as likely to be mildly active or inactive as people without, there is a strong relationship between vigorous physical activity and the respiratory condition.
Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.
Region Skåne, has selected LABVANTAGE to deliver a $4 million turn-key solution for digitizing the histopathological workflows of the whole region. The system will possibly be the largest such installation in the world and among the first in northern Europe.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 3 days ago
Mrs. Laura Sarfatis Miles, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 912 Nw 139th Street Pkwy, Edmond, OK 73013 Phone: 405-608-4447 Fax: 405-286-1261 | |
Jeffrey T Shaver, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3840 South Boulevard, Suite 101, Edmond, OK 73013 Phone: 405-471-5252 Fax: 405-726-8530 | |
Brian Dale Morgan, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 14701 N Santa Fe Ave, Edmond, OK 73013 Phone: 405-752-2733 Fax: 405-752-2172 | |
Robert D Gourley, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 920 S Bryant Ave, Ste 100, Edmond, OK 73034 Phone: 405-341-4238 Fax: 405-340-0269 | |
Dr. Thomas C Wolf, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3431 S Boulevard St, Suite 106, Edmond, OK 73013 Phone: 405-562-2036 Fax: 405-562-2116 | |
Dr. Sandeep N Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1851 S Kelly Ave Ste A, Edmond, OK 73013 Phone: 405-607-6699 Fax: 405-607-6685 |